basal insulin and glp-1 Adding a receptor agonist was not associated with a lower likelihood of discontinuing existing therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation Frontiers | Basal insulin intensification

Name: basal insulin and glp-1 Adding a receptor agonist was not associated with a lower likelihood of discontinuing existing therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation Frontiers | Basal insulin intensification
Brand: buntepalette-gmbh.de
SKU: 79733063699
Price: 27.89 USD
Availability: InStock
Rating: 4.5238000000000005 (15 reviews)

SKU: 79733063699

4.5

DKK27.89 DKK50.89

Pay in 4 interest-free payments of $6.97 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Live Spec

Frontiers Basal insulin intensification with GLP 1RA and dual GIP and GLP 1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta analysis Starting Insulin, GLP 1 at Same Time Brings Better Glycemic Control, Real World Data Show AJMC Unlocking the multifaceted roles of GLP 1: Physiological functions and therapeutic potential ScienceDirect EADSG Guidelines: Insulin Therapy in Diabetes PMC

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

The diluent was slightly hypoosmotic (see Section 2)